/PRNewswire/ Fermata, an outpatient psychiatric center of excellence, today announced a new clinical trial to study the SAINTâ„¢ Neuromodulation System for.
/PRNewswire/ SynerFuse, Inc., a privately held, clinical-stage medical device company focused on the development of a novel neuromodulation therapy concept.
/PRNewswire/ SynerFuse, Inc., a privately held, clinical-stage medical device company focused on the development of a novel neuromodulation therapy concept.